Abbiategrasso, Italy

Mario Scotti

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Flamma S.p.a.. Active years: 2025.


% Patents Active = 100.0


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Mario Scotti

Introduction

Mario Scotti is an accomplished inventor based in Abbiategrasso, Italy. He has made significant contributions to the field of chemistry, particularly in the purification processes of pharmaceutical compounds. His work is characterized by a focus on innovative methods that enhance the quality and efficacy of medicinal products.

Latest Patents

Mario Scotti holds a patent for a process titled "Process for the purification of (R)-2-amino-3-phenylpropyl carbamate." This invention relates to a method for purifying (R)-2-amino-3-phenylpropyl carbamate, which is crucial for its subsequent conversion into the corresponding hydrochloride salt, known as solriamfetol. The patent outlines the steps necessary to prepare a batch of purified solriamfetol, as well as the purified compound itself or its hydrochloride salt.

Career Highlights

Throughout his career, Mario has demonstrated a commitment to advancing pharmaceutical sciences. His work at Flamma S.p.a. has positioned him as a key player in the development of innovative purification techniques. His expertise in this area has contributed to the enhancement of drug formulations and their therapeutic applications.

Collaborations

Mario Scotti has collaborated with notable colleagues, including Francesco Chiesa and Leila Vahdati. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the pursuit of groundbreaking research.

Conclusion

Mario Scotti's contributions to the field of pharmaceutical chemistry through his innovative purification processes exemplify the impact of dedicated inventors in advancing medical science. His work continues to influence the development of effective therapeutic agents.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…